Nanoplasmonic Biosensors are advanced devices that leverage the unique optical properties of plasmonic nanoparticles for highly sensitive and label-free detection of biological molecules. These sensors operate based on the principle of surface plasmon resonance (SPR), where the interaction of light with free electrons at the surface of metallic nanoparticles induces a resonance condition that is highly sensitive to changes in the local refractive index. In nanoplasmonic biosensors, commonly used metals like gold and silver are structured into nanoscale geometries to enhance the surface plasmon resonance effect. Binding events, such as the attachment of biomolecules to the sensor surface, cause measurable shifts in the plasmon resonance frequency, enabling real-time monitoring of molecular interactions. The label-free nature of nanoplasmonic biosensors eliminates the need for fluorescent or radioactive labels, reducing assay complexity and increasing experimental efficiency. These sensors find applications in various fields, including medical diagnostics, environmental monitoring, and food safety. Nanoplasmonic biosensors offer exceptional sensitivity, enabling the detection of low concentrations of analytes, such as proteins, nucleic acids, and small molecules. Their miniaturized nature makes them suitable for integration into portable and point-of-care devices. Ongoing research in nanoplasmonics focuses on refining sensor designs, exploring novel materials, and expanding the range of detectable analytes. These biosensors hold great promise for advancing diagnostics, personalized medicine, and understanding molecular interactions at the nanoscale.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States